Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients

Background The launch of imatinib has turned chronic myeloid leukaemia (CML) into a chronic illness due to the dramatic improvement in survival. Several recent studies have demonstrated that poor adherence to imatinib may hamper the therapeutic outcomes and result in increased medical expenditures,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Li-Chia, Chen, Teng-Chou, Huang, Yaw-Bin, Chang, Chao-Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890041/
https://www.ncbi.nlm.nih.gov/pubmed/24154825
http://dx.doi.org/10.1007/s11096-013-9867-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890041/
https://www.ncbi.nlm.nih.gov/pubmed/24154825
http://dx.doi.org/10.1007/s11096-013-9867-8

Ejemplares similares